[en] Mesenchymal stem/stromal cells (MSCs) are considered a relevant therapeutic product for various clinical applications [...].
Disciplines :
Hematology
Author, co-author :
Merimi, Makram; Laboratory of Experimental Hematology, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Bruxelles, Belgium ; Genetics and Immune Cell Therapy Unit, LBBES Laboratory, Faculty of Sciences, University Mohammed Premier, Oujda 60000, Morocco
Lewalle, Philippe; Laboratory of Experimental Hematology, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Bruxelles, Belgium
Meuleman, Nathalie; Laboratory of Experimental Hematology, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Bruxelles, Belgium
Agha, Douâa Moussa; Laboratory of Experimental Hematology, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Bruxelles, Belgium
El-Kehdy, Hoda ; Laboratory of Pediatric Hepatology and Cell Therapy, UCLouvain, Institut de Recherche Expérimentale et Clinique, 1200 Brussels, Belgium
Bouhtit, Fatima; Laboratory of Experimental Hematology, Institut Jules Bordet, Université Libre de Bruxelles, 1000 Bruxelles, Belgium ; Genetics and Immune Cell Therapy Unit, LBBES Laboratory, Faculty of Sciences, University Mohammed Premier, Oujda 60000, Morocco
Ayoub, Sara; Department of Prosthodontics, Faculty of Dental Medicine, Lebanese University, Hadath, 10999 Beirut, Lebanon
Fahmi, Hassan; Osteoarthritis Research Unit, University of Montreal Hospital Research Center, Montreal, QC H2X 0A9, Canada
Lagneaux, Laurence; Laboratory of Clinical Cell Therapy, Institut Jules Bordet, Université Libre de Bruxelles, 1070 Brussels, Belgium
Najar, Mehdi ; Osteoarthritis Research Unit, University of Montreal Hospital Research Center, Montreal, QC H2X 0A9, Canada ; Laboratory of Clinical Cell Therapy, Institut Jules Bordet, Université Libre de Bruxelles, 1070 Brussels, Belgium
Language :
English
Title :
Mesenchymal Stem/Stromal Cell Therapeutic Features: The Bridge between the Bench and the Clinic.
Wobma, H.; Satwani, P. Mesenchymal stromal cells: Getting ready for clinical primetime. Transfus. Apher. Sci. 2021, 11, 103058. [CrossRef]
Girousse, A.; Mathieu, M.; Sastourné-Arrey, Q.; Monferran, S.; Casteilla, L.; Sengenès, C. Endogenous Mobilization of Mesenchy-mal Stromal Cells: A Pathway for Interorgan Communication? Front. Cell Dev. Biol. 2021, 8, 1534. [CrossRef] [PubMed]
Liu, Q.W.; Huang, Q.M.; Wu, H.Y.; Zuo, G.S.; Gu, H.C.; Deng, K.Y.; Xin, H.B. Characteristics and Therapeutic Potential of Human Amnion-Derived Stem Cells. Int. J. Mol. Sci. 2021, 22, 970. [CrossRef] [PubMed]
Miceli, V.; Bulati, M.; Iannolo, G.; Zito, G.; Gallo, A.; Conaldi, P.G. Therapeutic Properties of Mesenchymal Stromal/Stem Cells: The Need of Cell Priming for Cell-Free Therapies in Regenerative Medicine. Int. J. Mol. Sci. 2021, 22, 763. [CrossRef] [PubMed]
Samal, J.R.K.; Rangasami, V.K.; Samanta, S.; Varghese, O.P.; Oommen, O.P. Discrepancies on the Role of Oxygen Gradient and Culture Condition on Mesenchymal Stem Cell Fate. Adv. Healthc. Mater. 2021, e2002058. [CrossRef] [PubMed]
